Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery
Go back to Aptar Pharma and Massachusetts General Hospital Collaborate on Platform to Establish Predictive, Data-Driven Model for Advancing Nose-to-Brain Drug Delivery| APTARGROUP, Inc. (NYSE: ATR) | Delayed: 124.44 -1.06 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $125.50 | 52 Week High | $81.50 | |||
| Open | $125.49 | 52 Week Low | $66.33 | |||
| Day High | $125.77 | P/E | 49.38 | |||
| Day Low | $124.41 | EPS | $2.52 | |||
| Volume | 821,263 | |||||
